Clincosm LogoSign in Get a demo

Neoplasms

Showing 51 - 75 of 928
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)

Recruiting
  • Neoplasms
  • Secondary Malignant Neoplasm
  • SBRT + LDRT
  • Seoul, Korea, Republic of
  • +1 more
Feb 16, 2023

Cancer-associated Venous Thromboembolism

Recruiting
  • Venous Thromboses
  • Neoplasms
    • Wuhan, China
      Tongji Hospital
    Feb 6, 2023

    Tumors Trial in San Antonio (VIP236)

    Recruiting
    • Neoplasms
    • San Antonio, Texas
      NEXT Oncology San Antonio
    Feb 3, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 6, 2023

    NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +14 more
    • Glendale, California
    • +12 more
    Feb 2, 2023

    Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

    Active, not recruiting
    • Neoplasms
    • +3 more
    • Sarasota, Florida
    • +17 more
    Jan 27, 2023

    Anemia, Tumors, Chemotherapeutic-Induced Anemia Trial (Erythropoietin)

    Not yet recruiting
    • Anemia
    • +2 more
    • Erythropoietin
    • (no location specified)
    Jan 27, 2023

    Tumors Trial in Beijing ([68Ga]N188)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jan 27, 2023

    Tumors Trial in Worldwide (Encorafenib, Cetuximab, Oxaliplatin)

    Recruiting
    • Neoplasms
    • Phoenix, Arizona
    • +396 more
    Jan 25, 2023

    Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

    Recruiting
    • Tumor
    • +20 more
    • Mobile, Alabama
    • +81 more
    Jan 24, 2023

    Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

    Recruiting
    • Breast Neoplasms
    • +7 more
    • Canton, Ohio
      Gabrail Cancer Center
    Jan 24, 2023

    Clinical and Genetic Studies of Li-Fraumeni Syndrome

    Recruiting
    • Li-Fraumeni Syndrome
    • +2 more
      • Bethesda, Maryland
      • +1 more
      Jan 25, 2023

      Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

      Completed
      • Neoplasms
      • FdCyd + THU
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Collection of Tissue Samples for Cancer Research

      Recruiting
      • Neoplasms
      • +3 more
      • Biopsy
      • Atlanta, Georgia
      • +9 more
      Jan 23, 2023

      Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

      Recruiting
      • Neoplasms
      • Solid Tumors
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Tumors Trial in Spain, United Kingdom, United States (BI 1387446, BI 754091)

      Active, not recruiting
      • Neoplasms
      • BI 1387446
      • BI 754091
      • Chapel Hill, North Carolina
      • +7 more
      Jan 23, 2023

      Tumors Trial in Belgium, Japan, United States (BI 907828, BI 754091, BI 754111)

      Recruiting
      • Neoplasms
      • BI 907828
      • +2 more
      • Santa Monica, California
      • +16 more
      Jan 23, 2023

      Tissue Specimens From Solid Tumors or Blood Disorders and Their

      Recruiting
      • Neoplasms
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

        Recruiting
        • Neoplasms
        • Birmingham, Alabama
        • +62 more
        Jan 19, 2023

        Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

        Recruiting
        • Neoplasms
        • Nilotinib and Paclitaxel
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        Tumors Trial in Worldwide (Docetaxel, Feladilimab)

        Completed
        Has Results
        • Neoplasms
        • Saint Louis, Missouri
        • +42 more
        Dec 22, 2022

        Tumors Trial in China (Atezolizumab)

        Recruiting
        • Neoplasms
        • Beijing City, China
        • +16 more
        Jan 12, 2023

        Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

        Active, not recruiting
        • Hematologic Neoplasm
        • Neoplasms
        • Gainesville, Florida
        • +2 more
        Jan 12, 2023

        Tumors Trial in Canada, United Kingdom, United States (BI 754091)

        Active, not recruiting
        • Neoplasms
        • BI 754091
        • Sarasota, Florida
        • +12 more
        Jan 9, 2023

        Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

        Active, not recruiting
        • Neoplasms
        • Carcinoma, Non-Small-Cell Lung
        • BI 754111
        • BI 754091
        • Miami, Florida
        • +14 more
        Jan 9, 2023